Definition
- Essential:
- A glial neoplasm with chordoid features located In the anterior 3rd ventricle
- Desirable:
- Nuclear thyroid transcription factor 1 (TTF1) immunopositivity
- PRKCA p.D463H mutation or DNA methylation profile aligning with chordoid glioma
- WHO CNS 2016 Old: A slow-growing, non-invasive glial tumour located in the third ventricle, histologically characterized by clusters and cords of epithelioid tumour cells expressing GFAP, within a variably mucinous stroma typically containing a lymphoplasmacytic infiltrate.
Numbers
- Rare: 80 cases reported
- 46 years
- Male: Female = 1:2
CNS WHO grading
- Grade 2
Localisation
- Occupy the anterior portion of the third ventricle
Origin
- Arise in the region of the lamina terminalis in the ventral wall of the third ventricle
- Ependymal cell: because CG3rd has microvilli and hemidesmosomes-like structure
Clinical features
- Obstructive hydrocephalus, including headache, nausea, vomiting, and ataxia
- Hypothalamic compression: pituitary dysfunction hypothyroidism, amenorrhoea, and diabetes insipidus),
- Chiasmatic compression: visual field disturbance
- Personality changes/psychiatric abnormalities
Radiology
- Hypothyroidism, amenorrhoea, and diabetes insipidus),well-circumscribed ovoid masses within the anterior third ventricle
- T1-isointense to brain and show strong, homogeneous contrast enhancement
- Most tumours are continuous with the hypothalamus and some appear to have an intrinsic anterior hypothalamic component, suggesting a potential site of origin
Histopathology
- Micro
- Solid neoplasms, most often composed of clusters and cords of epithelioid tumour cells within a variably mucinous stroma that typically contains a lymphoplasmacytic infiltrate
- Other less common histological pattern;
- A solid pattern with sheets of polygonal epithelioid tumour cells without mucinous stroma,
- A fusiform pattern with groups of spindle shaped cells among loose collagen, and
- A fibrosing pattern with abundant fibrosis.
- More in older patients
- Mitoses are absent in most tumours; when present, they are rare (< 1 mitosis per 10 high-power fields)
- Consistent with their radiographical appearance, the tumours are architecturally solid and show little tendency to infiltrate surrounding brain structures.
- Reactive astrocytes, Rosenthal fibres, and often chronic inflammatory cells including lymphocytes, plasma cells, and Russell bodies are seen in adjacent nonneoplastic tissue
- + GFAP. TTF1Vimentin, CD34, EGFR, Merlin
- Variable S100, EMA, cytokeratin
- - Neuronal and neuroendocrine markers (e.g. synaptophysin, neurofilaments, and chromogranin-A)
- Ki-67 proliferation index is low, with values of 0-1.5%
Differential diagnosis
- Chordoid meningiomas usually contain small foci of classic meningioma with whorl formation and psammoma bodies; they are also immunopositive for EMA, but negative for GFAP and CD34 {2235}.
- Chordomas strongly express cytokeratins and brachyury, but lack immunoreactivity for GFAP and CD34.
Prognosis
- Gross total resection is the treatment of choice and can result in long-term recurrence-free survival
- The tumours’ location within the third ventricle and their attachment to hypothalamic and suprasellar structures often make complete resection impossible.
- Postoperative tumour enlargement has been noted in half of all patients who undergo subtotal resection.
- 20% of the patients died in the perioperative period or from tumour regrowth